• B. Ulsamer
  • A. Doenicke


Definition: Muskelrelaxanzien (MR) sind Substanzen, die eine reversible Lähmung der Skelettmuskulatur verursachen.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adams AK, Salt PJ (1985) The use of neuromuscular blocking agents in ophtalmic surgery. Clin Anaesth 3: 435Google Scholar
  2. 2.
    Agoston S, Richardson FJ (1985) Pipecuronium bromide (Arduan) — a new long-acting non-depolarizing neuromuscular blocking drug. Clin Anaesth 3: 361Google Scholar
  3. 3.
    Agoston S, Vermeer GA, Kersten UW, Scaf AHJ (1978) A preliminary investigation of the renal and hepatic excretion of gallamine triethiodide in man. Br J Anaesth 50: 345PubMedCrossRefGoogle Scholar
  4. 4.
    Arden JR., Lynam DP, Castagnoli KP, Canfell PC, Cannon JG, Miller RD (1988) Vecuronium in alcoholic liver disease: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 68: 771PubMedCrossRefGoogle Scholar
  5. 5.
    Assem ESK, Symons IE (1989) Anaphylaxis due to suxamethonium in a 7-year-old child: a 14-year follow up with allergy testing. Anaesthesia 44: 121PubMedCrossRefGoogle Scholar
  6. 6.
    Azar I (1984) The response of patients with neuromuscular disorders to muscle relaxants: a review. Anesthesiology 61: 173PubMedCrossRefGoogle Scholar
  7. 7.
    Azar I, Pham AN, Karambelkar DJ, Lear E (1983) The heart rate following edrophonium-atropine and edrophonium-glycopyrrolate mixtures. Anesthesiology 59: 139PubMedCrossRefGoogle Scholar
  8. 8.
    Baraka A (1977) Self-taming of succinylcholine — induced fasciculations. Anesthesiology 46: 292PubMedCrossRefGoogle Scholar
  9. 9.
    Baraka A, Yazigi A (1987) Neuromuscular interaction of magnesium with succinylcholine — vecuronium sequence in the eclamptic paturient. Anesthesiology 67: 806PubMedCrossRefGoogle Scholar
  10. 10.
    Basta SJ, Ali HH, Savarese JJ, Sunder N, Gionfriddo M, Cloutier G, Lineberry C, Cato AE (1982) Clinical pharmacology of atracurium besylate (BW33A): a new nondepolarizing muscle relaxant. Anesth Analg 61: 723PubMedCrossRefGoogle Scholar
  11. 11.
    Basta SJ, Debros F, Savarese JJ, Ali HH, Embree P, Lai A, Schwartz A, De Angelis R, Gallagher M, James N (1988) BW A938U pharmacokinetics and dynamics in healthy surgical patients under isoflurane anesthesia. Anesth Analg 67:S9CrossRefGoogle Scholar
  12. 12.
    Basta SJ, Savarese JJ, Ali HH, Sunder N, Moss J, Gionfriddo M, Embree P (1983) Vecuronium does not alter serum histamine within the clinical dose range. Anesthesiology 59: A 273CrossRefGoogle Scholar
  13. 13.
    Bencini AF, Scaf AHJ, Sohn YJ, Meistelmann C, Lien-hart A, Kersten UW, Schwarz S, Agoston S (1986) Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure. Anesth Analg 65: 245PubMedCrossRefGoogle Scholar
  14. 14.
    Bencini AF, Scaf AHJ, Sohn YJ, Kersten-Kleef UW, Agoston S (1986) Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 58: 988PubMedCrossRefGoogle Scholar
  15. 15.
    Bevan DR, Bevan JC, Donati F (1988) Muscle relaxants in clinical anesthesia. Year Book Medical Publishers, Chicago LondonGoogle Scholar
  16. 16.
    Bikhazi GB, Leung I, Flores C, Mikati HMJ, Foldes FF (1988) Potentiation of neuromuscular blocking agents by calcium channel blockers in rats. Anesth Analg 67: 1PubMedCrossRefGoogle Scholar
  17. 17.
    Birch AA, Mitchell GD, Playford GA, Lang CA (1969) Changes in serum potassium response to succinylcholine following trauma. JAMA 210: 490PubMedCrossRefGoogle Scholar
  18. 18.
    Boehm R (1897) Ueber Curare und Curarealkaloide. Arch Pharmakol 235: 660CrossRefGoogle Scholar
  19. 19.
    Bossa R, Galatulas I (1985) Neuromuscular blocking activity of H2 receptor antagonists. Br J Pharmacol [Suppl] 86: 779PGoogle Scholar
  20. 20.
    Bovet D, Bovet-Nitti F, Guarino S, Longo VG, Marotta M (1949) Proprieta farmachodinamiche di alcuni derivati della succinilcolina dotati di azione curarica. Rend Inst Sup Sanita (Roma) 12: 106Google Scholar
  21. 21.
    Bowman WC (1980) Prejunctional and post junctional cholinoceptors at the neuromuscular junction. Anesth Analg 59: 935PubMedCrossRefGoogle Scholar
  22. 22.
    Bowman WC, Marshall IG, Gibb AJ (1985) Is there feedback control of transmitter release at the neuromuscular junction? In: Katz RL (ed) Muscle relaxants. Grüne & Stratton, Orlando, p39Google Scholar
  23. 23.
    Brett RS, Schmidt JH, Gage JS, Schartel SA, Poppers PJ (1987) Measurement of acetylcholine receptor concentration in skeletal muscle from a patient with multiple sclerosis and resistance to atracurium. Anesthesiology 66: 837PubMedCrossRefGoogle Scholar
  24. 24.
    Brom van den RHG, Wierda JMKH, Agoston S (1987) Pharmacokinetics of atracurium and metabolites in normal and renal failure patients. Anesthesiology 67: A 606CrossRefGoogle Scholar
  25. 25.
    Bros de F, Basta SJ, Ali HH, Wargin W, Welch R (1987) Pharmacokinetics and pharmacodynamics of BW B1090U in healthy surgical patients receiving N2O/O2 isoflurane anesthesia. Anesthesiology 67: A 609CrossRefGoogle Scholar
  26. 26.
    Bros de F, Okutani R, Lai A, Lawrence KW, Basta S (1987) Phenytoin does not interfere with atracurium pharmacokinetics and pharmacodynamics. Anesthesiology 67: A 607CrossRefGoogle Scholar
  27. 27.
    Brotherton WP, Matteo RS (1981) Pharmacokinetics and pharmacodynamics of metocurine in humans with and without renal failure. Anesthesiology 55: 273PubMedCrossRefGoogle Scholar
  28. 28.
    Brücke H, Ginzel KH, Klupp H, Pfaffenschlager F, Werner G (1951) Bis-cholinester von Dicarbonsäuren als Muskelrelaxantien in der Narkose. Wien Klin Wochenschr 63: 464PubMedGoogle Scholar
  29. 29.
    Burns BD, Paton WDM (1951) Depolarization of the motor endplate by decamethonium and acetylcholine. J Physiol (Lond) 115: 41Google Scholar
  30. 30.
    Bush GH (1985) Neuromuscular blockade. Use in paediatric surgery and intensive care. Clin Anaesth 3: 405Google Scholar
  31. 31.
    Buzello W, Agoston S (1978) Comparative clinical pharmacokinetics of tubocurarine, gallamine, alcuronium and pancuronium. Anaesthesist 27: 313PubMedGoogle Scholar
  32. 32.
    Buzello W, Huttarsch H (1988) Muscle relaxation in patients with Duchenne’s muscular dystrophy. Use of vecuronium in two cases. Br J Anaesth 60: 228CrossRefGoogle Scholar
  33. 33.
    Buzello W, Schluermann D, Pollmaecher T, Spillner G (1987) Unequal effects of cardiopulmonary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium, and vecuronium. Anesthesiology 66: 842PubMedCrossRefGoogle Scholar
  34. 34.
    Buzello W, Williams SCH, Chandra P, Watkins ML, Dozier DS (1985) Vecuronium and porcine malignant hyperthermia. Anesth Analg 64: 515PubMedCrossRefGoogle Scholar
  35. 35.
    Camp CE, Tessem J, Adenwala J, Joyce TH (1987) Vecuronium and prolonged neuromuscular blockade in postpartum patients. Anesthesiology 67: 1006PubMedCrossRefGoogle Scholar
  36. 36.
    Cannon JE, Fahey MR, Castagnoli KP, Furuta T, Can-fell PC, Sharma M, Miller RD (1987) Continuous infusion of vecuronium: the effect of anesthetic agents. Anesthesiology 67: 503PubMedCrossRefGoogle Scholar
  37. 37.
    Changeux JP, Devillers-Thiery A, Chemonilli P (1984) Acetylcholine rezeptor. An allosteric membrane protein. Science 225: 1335Google Scholar
  38. 38.
    Chappie DJ, Clarke JS (1983) Pharmacological action of breakdown products of atracurium and related substances. Br J Anaesth 55: 11 SGoogle Scholar
  39. 39.
    Churchill-Davidson HC, Christie TH, Wise RP (1960) Dual neuromuscular block in man. Anesthesiology 21: 144PubMedCrossRefGoogle Scholar
  40. 40.
    Churchill-Davidson HC, Wise RP (1964) The response of the newborn infant to muscle relaxants. Can Anaesth Soc J 11: 1PubMedCrossRefGoogle Scholar
  41. 41.
    Collier C (1975) Suxamethonium pains and fasciculations. Proc R Soc Med 68: 105PubMedGoogle Scholar
  42. 42.
    Cook DR, Fisher CG (1975) Neuromuscular blocking effects of succinylcholine in infants and children. Anesthesiology 42: 662PubMedCrossRefGoogle Scholar
  43. 43.
    Cook DR, Stiller RL, Weakly JN, Chakravorti S, Bran-dom BW, Welch RM (1989) In vitro metabolism of mivacurium chlorid (BW B1090U) and succinylcholine. Anesth Analg 68: 452PubMedCrossRefGoogle Scholar
  44. 44.
    Cowgill DB, Mostello LA, Shapiro HM (1974) Encephalitis and a hyperkalemic response to succinylcholine. Anesthesiology 40: 409PubMedCrossRefGoogle Scholar
  45. 45.
    Cronnelly R, Fisher DM, Miller RD, Gencarelli P, Nguyen-Gruenke L, Castagnoli N (1983) Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) and pancuronium in anesthetized humans. Anesthesiology 58: 405PubMedCrossRefGoogle Scholar
  46. 46.
    Cronnelly R, Morris RB (1982) Antagonism of neuromuscular blockade. Br J Anaesth 54: 183PubMedCrossRefGoogle Scholar
  47. 47.
    Crul JF (1981) Klinische Pharmakokinetik von Succinyl-cholin. In: Buzello W (Hrsg) Muskelrelaxantien. Thieme, Stuttgart New York (Intensivmed Notfallmed Anästh, Bd 30, S 91)Google Scholar
  48. 48.
    Dailey PA, Fisher DM, Shnider SM, Baysinger CL, Shinohara Y, Miller RD, Abboud TK, Kim KC (1984) Pharmacokinetics, placental transfer, and neonatal effects of vecuronium and pancuronium administered during cesarean section. Anesthesiology 60: 569PubMedCrossRefGoogle Scholar
  49. 49.
    Dale HH, Feldberg W (1934) Chemical transmission at motor nerve endings in voluntary muscle. J Physiol (Lond) 81: 39Google Scholar
  50. 50.
    Dale HH, Feldberg W, Vogt M (1936) Release of acetylcholine at voluntary motor nerve endings. J Physiol (Lond) 86: 353Google Scholar
  51. 51.
    Day NS, Blake GJ, Standaert FG, Dretchen KL (1983) Characterization of the train of four response in fast and slow muscles: effect of d-tubocurarine, pancuronium, and vecuronium. Anesthesiology 58: 414PubMedCrossRefGoogle Scholar
  52. 52.
    Denny NM, Kneeshaw JD (1986) Vecuronium and atra-curium infusions during hypothermic cardiopulmonary bypass. Anaesthesia 41: 919PubMedCrossRefGoogle Scholar
  53. 53.
    Doenicke A (1974) Pseudo Cholinesterasen. In: Schwiegk H (Hrsg) Handbuch der inneren Medizin, Bd 7, Teil 1. Springer, Berlin Heidelberg New York, S 761Google Scholar
  54. 54.
    Doenicke A, Gürtner T, Kreutzberg G, Remes J, Spiess W, Steinbereithner K (1963) Serum Cholinesterase Anenzymia. Acta Anaesthesiol Scand 7: 59PubMedCrossRefGoogle Scholar
  55. 55.
    Doenicke A, Holle F, Frey HH (1962) Praktische Bedeutung der Plasmacholinesterasebestimmung und ihres atypischen Verhaltens gegenüber Succinylbischolin. Anaesthesist 11: 146PubMedGoogle Scholar
  56. 56.
    Doenicke A, Krumey I, Kugler J, Klempa J (1968) Experimental studies of the breakdown of epontol: Determination of propanidid in human serum. Br J Anaesth 40: 415PubMedCrossRefGoogle Scholar
  57. 57.
    Doenicke A, Lorenz W, Dick W, Ennis M, Ulsamer B, Sitter H, Seibert W (1991) Clinical significance of low level histamine release induced by anaesthetic drugs: atracurium as a paradigma. (in press)Google Scholar
  58. 58.
    Doenicke A, Schmidinger ST, Krumey I (1968) Suxamethonium and serum Cholinesterase. Br J Anaesth 40: 834PubMedCrossRefGoogle Scholar
  59. 59.
    Donati F, Antzaka C, Bevan DR (1986) Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans. Anesthesiology 65: 1PubMedCrossRefGoogle Scholar
  60. 60.
    Donati F, Bevan DR (1985) Suxamethonium. Clin Anaesth 3: 371Google Scholar
  61. 61.
    Donati F, McCaroll SM, Antzaka C, McCready D, Bevan DR (1987) Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine. Anesthesiology 66: 471PubMedCrossRefGoogle Scholar
  62. 62.
    Donlon JV, Savarese JJ, Ali HH, Teplik RS (1980) Human dose-response curves for neuromuscular blocking drugs. A comparison of two methods of constructions and analysis. Anesthesiology 53: 161Google Scholar
  63. 63.
    Duncalf D, Chaudrey I, Aoki T, Nagashima H, Foldes FF (1983) Potentiation of pancuronium, vecuronium and atracurium by d-tubocurarine or metocurine. Anesthesiology 59:A 292Google Scholar
  64. 64.
    Duvaldestin P, Agoston S, Henzel D, Kersten UW, Desmonts JM (1978) Pancuronium pharmacokinetics in patients with liver cirrhosis. Br J Anaesth 50: 1131PubMedCrossRefGoogle Scholar
  65. 65.
    Duvaldestin P, Berger JL, Videcoq M, Desmonts JM (1982) Pharmacokinetics and pharmacodynamics of ORG NC 45 in patients with cirrhosis. Anesthesiology 57:A238CrossRefGoogle Scholar
  66. 66.
    Duvaldestin P, Henzel D, Demetriou M, Desmonts JM (1978) Pharmacokinetics of fazadinium in man. Br J Anaesth 50: 773PubMedCrossRefGoogle Scholar
  67. 67.
    Duvaldestin P, Lebrault C, Chauvin M (1985) Pharma-kokinetics of muscle relaxants in patients with liver disease. Clin Anaesth 3: 293Google Scholar
  68. 68.
    Duvaldestin P, Saada A, Berger JL, D’Hollander A, Desmonts JM (1982) Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects. Anesthesiology 56: 36PubMedCrossRefGoogle Scholar
  69. 69.
    Eisenkraft JB, Book WJ, Papatestas AE, Hubbard M (1989) Sensitivity to vecuronium in myasthenia gravis: a dose-response study. Anesth Analg 68: S80Google Scholar
  70. 70.
    Engbaeck L (1954) The pharmacological actions of magnesium ions with particular reference to the neuromuscular and cardiovascular systems. Pharmacol Rev 4: 396Google Scholar
  71. 71.
    Erkola O (1988) Prevention of succinylcholine-induced muscle pains with alcuronium, atracurium, d-tubocurarine and vecuronium. 9th W Congr Abstr Scient Pap II: A0569Google Scholar
  72. 72.
    Everett AJ, Lowe LA, Wilkinson S (1970) Revision of the structure of ( + )-tubocurarine chloride and ( + )-chon-drocurarine. J Chem Soc 16: 1020Google Scholar
  73. 73.
    Fahey MR, Hosobuchi Y, Canfell C, Tabaoda T, Shi WZ, Miller RD (1985) Cerebrospinal fluid concentrations of laudanosine in man. Anesthesiology 63: A 312CrossRefGoogle Scholar
  74. 74.
    Fahey MR, Morris RB, Miller RD, Nguyen TL, Upton RA (1981) Pharmacokinetics of Org NC 45 (Norcuron) in patients with and without renal failure. Br J Anaesth 53: 1049PubMedCrossRefGoogle Scholar
  75. 75.
    Fahey MR, Rupp SM, Fisher DM, Miller RD, Sharma M, Canfell C, Castagnoli K, Hennis PJ (1984) The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology 61: 699PubMedCrossRefGoogle Scholar
  76. 76.
    Fahey MR, Rupp SM, Canfell C, Fisher DM, Miller RD, Sharma M, Castagnoli K, Hennis PJ (1985) Effect of renal failure on laudanosin excretion in man. Br J Anaesth 57: 1049PubMedCrossRefGoogle Scholar
  77. 77.
    Farman JV, Turner JM, Blanloeil Y (1986) Atracurium infusion in liver transplantation. Br J Anaesth 58: 96 SCrossRefGoogle Scholar
  78. 78.
    Farrell AM, Gowland G, McDowell JM, Simpson KH, Watkins J (1988) Anaphylactoid reaction to vecuronium followed by systemic reaction to skin testing. Anaesthesia 43: 207PubMedCrossRefGoogle Scholar
  79. 79.
    Feldman SA, Liban JB (1987) Vecuronium — a variable dose technique. Anaesthesia 42: 199PubMedCrossRefGoogle Scholar
  80. 80.
    Feldman SA (1987) Neuromuscular blocking agents. In: Feldman SA, Scurr CF, Paton W (eds) Drugs in anaesthesia: mechanisms of action. Arnold, London, p 160Google Scholar
  81. 81.
    Fisher DM, Canfell PC, Miller RD (1984) Stability of atracurium administered by infusion. Anesthesiology 61: 347PubMedCrossRefGoogle Scholar
  82. 82.
    Fisher DM, Canfell PC, Fahey MR, Rosen JI, Rupp SM, Sheiner LW, Miller RD (1986) Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology 65: 6PubMedCrossRefGoogle Scholar
  83. 83.
    Fisher DM, Cronnelly R, Sharma M, Miller RD (1984) Clinical pharmacology of edrophonium in infants and children. Anesthesiology 61: 428PubMedCrossRefGoogle Scholar
  84. 84.
    Fisher DM, Miller RD (1983) Neuromuscular effects of vecuronium (ORG NC 45) in infants and children during N2O, halothane anesthesia. Anesthesiology 58: 519PubMedCrossRefGoogle Scholar
  85. 85.
    Fisher DM, Rosen JI (1986) A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants. Anesthesiology 65: 286PubMedCrossRefGoogle Scholar
  86. 86.
    Fisher MMcD (1978) Anaphylactic reactions to gallamine triethiodide. Anaesth Intensive Care 6: 62PubMedGoogle Scholar
  87. 87.
    Fisher MMcD (1982) The epidemiology of anaesthetic anaphylactoid reactions in Australasia. Klin Wochenschr 60: 1017PubMedCrossRefGoogle Scholar
  88. 88.
    Fogdall RP, Miller RD (1975) Neuromuscular effects of enflurane, alone and combined with d-tubocurarine, pancuronium, and succinylcholine, in man. Anesthesiology 42: 173PubMedCrossRefGoogle Scholar
  89. 89.
    Foldes FF, Mc Nall PG, Borrego-Hinjosa JH (1952) Succinylcholine: a new approach to muscular relaxation in anaesthesiology. N Engl J Med 247: 596PubMedCrossRefGoogle Scholar
  90. 90.
    Foldes FF, Nagashima H, Nguyen HD, Weiss R, Goldiner PL (1986) The human cumulative dose-response of pipecuronium bromide under balanced anesthesia. Anesthesiology 65:A116CrossRefGoogle Scholar
  91. 91.
    Forbes AR, Cohen NH, Eger EI (1979) Pancuronium reduces halothane requirement in man. Anesth Analg 58: 497PubMedGoogle Scholar
  92. 92.
    Forstmann V, Schuh FT (1988) Wirkungseintritt und Intubationsbedingungen nach Atracurium, Vecuronium und Suxamethonium. Anaesthesist 37: 311PubMedGoogle Scholar
  93. 93.
    Frankville DD, Drummond JC (1987) Hyperkalemia after succinylcholine administration in a patient with closed head injury without paresis. Anesthesiology 67: 264PubMedCrossRefGoogle Scholar
  94. 94.
    Futo J, Kupferberg JP, Moss J, Fahey MR, Cannon JE, Miller RD (1988) Vecuronium inhibits histamine N-methyltransferase. Anesthesiology 69: 92PubMedCrossRefGoogle Scholar
  95. 95.
    Ghoneim MM, Kramer SE, Bannow R, Pandya H, Roüth JI (1973) Binding of d-tubocurarine to plasma proteins in normal man and in patients with hepatic or renal disease. Anesthesiology 39: 410PubMedCrossRefGoogle Scholar
  96. 96.
    Gibson FM, Mirakhur RK, Clarke RSJ, Lavery GG (1985) Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium. Br J Anaesth 57: 1060PubMedCrossRefGoogle Scholar
  97. 97.
    Gilly H, Redl G, Streinzer W, Zrunek M, Draxler V (1986) Zur Pharmakodynamik von Vecuronium an Stimmband-und Thenarmuskulatur. Anaesthesist 35: 661PubMedGoogle Scholar
  98. 98.
    Glass PSA, Ginsberg B, Quill T, Shafron D, Ascher J, Douglas C (1988) Onset, duration and reversal following doxacurium chloride (BW A938U) when combined with isoflurane. Anesth Analg 67: S 73CrossRefGoogle Scholar
  99. 99.
    Glass PSA, Wilson W, Mace JA, Wagoner R (1989) Is the priming principle both effective and safe? Anesth Analg 68: 127PubMedCrossRefGoogle Scholar
  100. 100.
    Glisson SN, Sanchez MM, El-Etr AA, Lim RA (1980) Nitroglyzerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium. Anesth Analg 59: 117PubMedCrossRefGoogle Scholar
  101. 101.
    Goedde H, Doenicke A, Altland K (1967) Pseudo Cholinesterasen. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  102. 102.
    Goldberg ME, Larijani GE, Sosis M, Azad SS, Williams JJ, Lessin JB, Marr AT, Lobes PF, Asher J, Weakly JN, Seltzer JL (1988) A comparison of endotracheal intubation conditions and recovery following intubating doses of mivacurium chloride or succinylcholine in outpatient surgery. Anesth Analg 67: S 77CrossRefGoogle Scholar
  103. 103.
    Goudsouzian NG, Alifimoff JK, Liu LMP, Foster V, McNulty B, Savarese JJ (1989) Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane. Br J Anaesth 62: 263PubMedCrossRefGoogle Scholar
  104. 104.
    Gramstad L (1987) Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine. Br J Anaesth 59: 995PubMedCrossRefGoogle Scholar
  105. 105.
    Gravlee GP, Ramsey FM, Roy RC, Angert KC, Rogers AT, Pauca AL (1988) Rapid administration of a narcotic and neuromuscular blocker: a hemodynamic comparison of fentanyl, sufentanil, pancuronium, and vecuronium. Anesth Analg 67: 39PubMedCrossRefGoogle Scholar
  106. 106.
    Griffith HR, Johnson GE (1942) The use of curare in general anesthesia. Anesthesiology 3: 418CrossRefGoogle Scholar
  107. 107.
    Gronert GA, Theye RA (1974) Effect of succinylcholine on skeletal muscle with immobilization atrophy. Anesthesiology 40: 268PubMedCrossRefGoogle Scholar
  108. 108.
    Gronert GA, Theye RA (1975) Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 43: 89PubMedCrossRefGoogle Scholar
  109. 109.
    Gürtner T, Kreutzberg G, Doenicke A (1963) Comparative studies on Cholinesterase activity in serum and liver cells. Acta Anaesthesiol Scand 7: 69PubMedCrossRefGoogle Scholar
  110. 110.
    Harle DG, Baldo BA, Fisher MM (1985) Cross-reactivity of metocurine, atracurium, vecuronium and fazadinium with IgE antibodies from patients unexposed to these drugs but allergic to other myoneural blocking drugs. Br J Anaesth 57: 1073PubMedCrossRefGoogle Scholar
  111. 111.
    Harris MM, Stirt JA, Broaddus WF, Cook DR (1987) Cerebrospinal fluid laudanosin kinetics in children. Anesthesiology 67:A 506CrossRefGoogle Scholar
  112. 112.
    Harris W, Whittaker M (1961) Differential inhibition of human serum Cholinesterase with fluoride; recognition of two new phenotypes. Nature (Lond) 191: 496CrossRefGoogle Scholar
  113. 113.
    Harrison GA (1972) The cardiovascular effects and some relaxant properties of four relaxants in patients about to undergo cardiac surgery. Br J Anaesth 44: 485PubMedCrossRefGoogle Scholar
  114. 114.
    Hartmann GS, Fiamengo SA, Riker WF (1986) Succinylcholine: mechanism of fasciculations and their prevention by d-tubocurarine or diphenylhydantoin. Anesthesiology 65: 405CrossRefGoogle Scholar
  115. 115.
    Helpap B, Gullotta F, Schulteam Esch J (1983) Maligne Hyperthermic Intensivmed Notfallmed Anästh, Bd 42Google Scholar
  116. 116.
    Hennis PJ, Stanski DR (1985) Pharmacokinetic and pharmacodynamic factors that govern the clinical use of muscle relaxants. In: Katz RL (ed) Muscle relaxants. Grune & Stratton, Orlando, p 179Google Scholar
  117. 117.
    Hilgenberg JC (1983) Comparison of the pharmacology of vecuronium and atracurium with that of other currently available muscle relaxants. Anesth Analg 62: 524PubMedCrossRefGoogle Scholar
  118. 118.
    d’Hollander A, Massaux F, Nevelsteen M, Agoston SJ (1982) Age-dependent dose-response relationship of ORG NC 45 in anaesthetized patients. Br J Anaesth 54: 653CrossRefGoogle Scholar
  119. 119.
    Holle F, Doenicke A (1961) Cholinesterase in der Chirurgie. In: Bauer KH, Brunner A, Lindemann K (Hrsg) Ergebnisse der Chirurgie und Orthopädie, Bd 63, Springer, Berlin Güttingen Heidelberg, S 77CrossRefGoogle Scholar
  120. 120.
    Hughes R (1985) Local reactions and histamine release by atracurium. Anaesthesia 40: 593PubMedCrossRefGoogle Scholar
  121. 121.
    Hunt R, Taveau RM (1906) On the physiological action of certain choline derivatives and new methods for detecting choline. Br Med J 2: 1788CrossRefGoogle Scholar
  122. 122.
    Hunter JM, Jones RS, Utting JE (1984) Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function. Br J Anaesth 56: 941PubMedCrossRefGoogle Scholar
  123. 123.
    Ilias W, Lackner F, Zekert F (1985) Nifedipin und Vecuroniumbromid. Anaesthesist 34: 591PubMedGoogle Scholar
  124. 124.
    Ilias W, Steinbereithner K (1985) Zur Wechselwirkung der Ca-Antagonisten Nifedipin und Nisoldipin mit dem nichtdepolarisierenden Muskelrelaxans Vecuro-niumbromid im „in vivo“ Rattenpräparat. Anaesthesist 34: 588PubMedGoogle Scholar
  125. 125.
    Inoue K, El-Banayosy A, Stolarski L, Reichelt W (1988) Vecuronium induced bradycardia following induction of anaesthesia with etomidate or thiopentone, with or without fentanyl. Br J Anaesth 60: 10PubMedCrossRefGoogle Scholar
  126. 126.
    Jantzen J-PAH (1988) Anaesthesie und intraokularer Druck. Anaesthesist 37: 458PubMedGoogle Scholar
  127. 127.
    Joseph MM, Beatie C (1987) Effect of succinylcholine on recovery from vecuronium — a comparison of orbicularis oculi and adductor pollicis muscles. Anesthesiology 67:A 342CrossRefGoogle Scholar
  128. 128.
    Kalli I, Meretoja OA (1988) Infusion of atracurium in neonates, infants and children. A study of dose requirements. Br J Anaesth 60: 651PubMedCrossRefGoogle Scholar
  129. 129.
    Kalow W, Davies RO (1958) The activity of various esterase inhibitors towards atypical human serum Cholinesterase. Biochem Pharmacol 1: 183CrossRefGoogle Scholar
  130. 130.
    Kalow W, Genest K (1957) A method for the detection of atypical forms of human serum Cholinesterase. Determination of dibucain numbers. Can J Biochem Physiol 35: 339PubMedCrossRefGoogle Scholar
  131. 131.
    Kambam JR, Sastry BVR (1988) The effect of vecuronium on cholin acetyl transferase activity. 9th WCA Abstracts Vol II: A0543Google Scholar
  132. 132.
    Kaplan JA (1987) Cardiac anesthesia, 2nd ed, vol1. Saunders, Philadelphia London, p 151Google Scholar
  133. 133.
    Katz JA, Fragen RJ, Shanks CA, Dunn K, McNulty B, Rudd GD (1989) Dose-response relationships of doxacurium chloride in humans during anesthesia with nitrous oxide and fentanyl, enflurane, isoflurane, or halothane. Anesthesiology 70: 432PubMedCrossRefGoogle Scholar
  134. 134.
    Katz B, Thesleff S (1957) A study of „desensitization“ produced by acetylcholine at the motor end-plate. J Physiol (Lond) 138: 63Google Scholar
  135. 135.
    Keens SJ, Hunter JM, Snowdon SL, Utting JE (1987) Potentiation of the neuromuscular blockade produced by alcuronium with halothane, enflurane and isoflurane. Br J Anaesth 59: 1011PubMedCrossRefGoogle Scholar
  136. 136.
    Kennedy BR, Kelman GR (1970) Cardiovascular effects of alcuronium in man. Br J Anaesth 42: 625PubMedCrossRefGoogle Scholar
  137. 137.
    Kim C, Fuke N, Martyn JAJ (1988) Burn injury to rat increases nicotinic acetylcholine receptors in the diaphragm. Anesthesiology 68: 401PubMedCrossRefGoogle Scholar
  138. 138.
    Kohlschütter B, Baur H, Roth F (1976) Suxamethonium-induced hyperkalaemia in patients with severe intraabdominal infections. Br J Anaesth 48: 557PubMedCrossRefGoogle Scholar
  139. 139.
    Krieg N (1985) Pharmakodynamische Untersuchungen mit Vecuronium. Anaesthesist 34: 340PubMedGoogle Scholar
  140. 140.
    Krieg N, Crul JF, Booij LHDJ (1980) Relative potency of ORG NC 45, pancuronium, alcuronium and tubo-curarine in anaesthetized man. Br J Anaesth 52: 783PubMedCrossRefGoogle Scholar
  141. 141.
    Krieg N, Hendrick HL, Crul JF (1981) Influence of suxamethonium on the potency of ORG NC 45 in anaesthetized patients. Br J Anaesth 53: 259PubMedCrossRefGoogle Scholar
  142. 142.
    Kupferberg JP, James L, Seals CF (1987) Atracurium: inhibition of plasma Cholinesterase and degradation in vitro. Anesthesiology 67: A 602CrossRefGoogle Scholar
  143. 143.
    Laurence AS (1987) Myalgia and biochemical changes following intermittent suxamethonium administration. Anaesthesia 42: 503PubMedCrossRefGoogle Scholar
  144. 144.
    Laurence AS (1988) Serum myoglobin release following suxamethonium administration to children. Eur J Anaesth 5: 31Google Scholar
  145. 145.
    Laycock JRD, Baxter MK, Bevan JC, Sangwan S, Donati F, Bevan DR (1988) The potency of pancuronium at the adductor pollicis and diaphragm in infants and children. Anesthesiology 68: 908PubMedCrossRefGoogle Scholar
  146. 146.
    Lebowitz PW, Ramsey FM, Savarese JJ, Ali HH, de Bros FM (1981) Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone. Anesth Analg 60: 12PubMedCrossRefGoogle Scholar
  147. 147.
    Lebrault C, Berger JL, D’Hollander AA, Gomeni R, Henzel D, Duvaldestin P (1985) Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) in patients with cirrhosis. Anesthesiology 62: 601PubMedCrossRefGoogle Scholar
  148. 148.
    Lee C (1985) Succinylcholine: its past, present and future. In: Katz RL (ed) Muscle relaxants. Grune & Stratton, Orlando, p 69Google Scholar
  149. 149.
    Leigh MD, Mc Coy DD, Belton KM (1957) Bradycardia following intravenous administration of succinylcholine chloride to infants and children. Anesthesiology 18: 698PubMedCrossRefGoogle Scholar
  150. 150.
    Lidell J, Lehmann M, Silk E (1962) A silent pseudocholin-esterase gene. Nature (Lond) 193: 561CrossRefGoogle Scholar
  151. 151.
    Lincoff HA, Breinin GM, De Voe AG (1957) The effect of succinylcholine on the extraocular muscles. Am J Ophthalmol 43: 440PubMedGoogle Scholar
  152. 152.
    Matteo RS (1985) Neuromuscular blockade. Use in the elderly. Clin Anaesth 3: 421Google Scholar
  153. 153.
    Matteo RS, Nishitateno K, Pua EK, Spector S (1980) Pharmacokinetics of d-tubocurarine in man: effect of an osmotic diuretic on urinary excretion. Anesthesiology 52: 335PubMedCrossRefGoogle Scholar
  154. 154.
    Matteo RS, Pua EK, Khambatta HJ, Spector S (1977) Cerebrospinal fluid levels of d-tubocurarine in man. Anesthesiology 46: 396PubMedCrossRefGoogle Scholar
  155. 155.
    Meakin G, Shaw EA, Baker RD, Morris P (1988) Comparison of atracurium-induced neuromuscular blockade in neonates, infants and children. Br J Anaesth 60: 171PubMedCrossRefGoogle Scholar
  156. 156.
    Mercer JD (1984) A severe anaphylactic reaction of atracurium. Anaesth Intensive Care 12: 262PubMedGoogle Scholar
  157. 157.
    Meretoja OA, Wirtavuori K, Neuvonen PJ (1988) Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia. Anesth Analg 67: 21PubMedCrossRefGoogle Scholar
  158. 158.
    Merrett RA, Thompson CW, Webb FW (1983) In vitro degradation of atracurium in human plasma. Br J Anaesth 55: 61PubMedCrossRefGoogle Scholar
  159. 159.
    Metha MP, Sokoll MD, Gergis SD (1988) Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine. Eur J Anaesth 5: 15Google Scholar
  160. 160.
    Miller KW, Paton WDM, Smith RA (1973) Pressure reversal of anaesthesia and the critical volume hypothesis. Mol Pharmacol 9: 131PubMedGoogle Scholar
  161. 161.
    Miller RD (1982) Pharmacokinetics of competitive muscle relaxants. Br J Anaesth 54: 161PubMedCrossRefGoogle Scholar
  162. 162.
    Miller RD (1985) Neuromuscular blockade. Effect of renal disease. Clin Anaesth 3: 307Google Scholar
  163. 163.
    Miller RD, Agoston S, Van der Pol, Booij LHDJ, Crul JF, Ham J (1978) Hypothermia and pharmacokinetics and pharmacodynamics of pancuronium in the cat. J Pharmacol Exp Ther 207: 532PubMedGoogle Scholar
  164. 164.
    Miller RD, Rupp SM, Fisher DM, Cronnelly R, Fahey MR, Sohn YJ (1984) Clinical phamacology of vecuronium and atracurium. Anesthesiology 61: 444PubMedCrossRefGoogle Scholar
  165. 165.
    Miller RD, Way WL (1971) Inhibition of succinylcholine-induced increased intragastric pressure by nondepolarizing muscle relaxants and lidocain. Anesthesiology 34: 185PubMedCrossRefGoogle Scholar
  166. 166.
    Miller RD, Way WL, Hamilton WK, Layzer RB (1972) Succinylcholine-induced hyperkalemia in patients with renal failure? Anesthesiology 36: 138PubMedCrossRefGoogle Scholar
  167. 167.
    Miller RD, Way WL, Dolan MW, Stevens WC, Eger EI II (1972) The dependence of pancuronium and d-tubo-curarine induced neuromuscular blockades on alveolar concentrations of halothane and forane. Anesthesiology 37: 573PubMedCrossRefGoogle Scholar
  168. 168.
    Minton MD, Grosslight K, Stirt JA, Bedford RF (1986) Increases in intracranial pressure from succinylcholine: prevention by prior nondepolarizing blockade. Anesthesiology 65: 165PubMedCrossRefGoogle Scholar
  169. 169.
    Mirakhur RK, Jones CJ, Dundee JW (1980) Effects of intravenous administration of glycopyrrolate and atropine in anaesthetized patients. Anaesthesia 36: 277CrossRefGoogle Scholar
  170. 170.
    Mishima S, Yamamura T (1984) Anaphylactoid reaction to pancuronium. Anesth Analg 63: 865PubMedCrossRefGoogle Scholar
  171. 171.
    Moss J, Rosow CE, Savarese JJ, Philbin DM, Kniffen KJ (1981) Role of histamine in the hypotensive action of d-tubocurarine in humans. Anesthesiology 55: 19PubMedCrossRefGoogle Scholar
  172. 172.
    Moss J, Rosow CE (1983) Histamine release by narcotics and muscle relaxants in humans. Anesthesiology 59: 330PubMedCrossRefGoogle Scholar
  173. 173.
    Motsch J, Fuchs W, Hoch P, Kass V, Hutschenreuter K (1987) Side effects and changes in pulmonary function after fixed dose precurarization with alcuronium, pancuronium or vecuronium. Br J Anaesth 59: 1528PubMedCrossRefGoogle Scholar
  174. 174.
    Musich J, Walts LF (1986) Pulmonary aspiration after a priming dose of vecuronium. Anesthesiology 64: 517PubMedCrossRefGoogle Scholar
  175. 175.
    Nachmansohn D (1963) The chemical basis of Claude Bernard’s observation on curare. Biochem Z 338: 454PubMedGoogle Scholar
  176. 176.
    Nigrovic V, Pandya JB, Auen M, Wajskol A (1985) Inactivation of atracurium in human and rat plasma. Anesth Analg 64: 1047PubMedCrossRefGoogle Scholar
  177. 177.
    O’Hara DA, Fragen RJ, Shanks CA (1985) The effects of age on the dose-response curves for vecuronium in adults. Anesthesiology 63: 542PubMedCrossRefGoogle Scholar
  178. 178.
    Ornstein E, Matteo RS, Weinstein JA, Young WL (1988) The effect of maintenance dose vecuronium of metocurine induced neuromuscular blockade. Anesthesiology 69: 954PubMedCrossRefGoogle Scholar
  179. 179.
    O’Sullivan EP, Williams NE, Calvey TN (1988) Differential effects of neuromuscular blocking agents on suxamethonium-induced fasciculations and myalgia. Br J Anaesth 60: 367PubMedCrossRefGoogle Scholar
  180. 180.
    Pandey K, Badola RP, Kumar S (1972) Time course of intraocular hypertension produced by suxamethonium. Br J Anaesth 44: 191PubMedCrossRefGoogle Scholar
  181. 181.
    Panning B, Peest D, Kirchner E, Schedel I (1985) Anaphylaktoider Schock nach Alloferin. Anaesthesist 34: 211PubMedGoogle Scholar
  182. 182.
    Pansard IL, Chauvin M, Lebrault C, Gauneau P, Duval-destin P (1987) Effect of an intubating dose of succinylcholine and atracurium on the diaphragm and the adductor pollicis muscle in humans. Anesthesiology 67: 326PubMedCrossRefGoogle Scholar
  183. 183.
    Parker CJR, Hunter JM (1988) The pharmacokinetics of atracurium and its metabolite, laudanosine, in the cirrhotic patient. 9th WCA Abstr Sci Pap vol II: A 5014Google Scholar
  184. 184.
    Paskov DS, Agoston S, Bowman WC (1986) 4-Aminopyridin hydrochloride (pymadin). In: Kharkevich DA (ed) New neuromuscular blocking agents. Springer, Berlin Heidelberg New York Tokyo (Handbook of experimental pharmacology, vol 79, p 679)CrossRefGoogle Scholar
  185. 185.
    Paton WDM, Waud DR (1967) The margin of safety of muscle relaxant drugs. J Physiol (Lond) 191: 59Google Scholar
  186. 186.
    Plütz J, Braun J (1987) Der Einfluß ausgewählter Narkotika auf die Serumkonzentration von Myoglobin nach Gabe von Suceinylcholin. Anaesthesist 36: 352Google Scholar
  187. 187.
    Plütz J, Kutz N, Sommerburg C, Braun J (1989) Injektionsgeschwindigkeit von Suceinyleholin und neuromuskulärer Wirkungseintritt, Serumkalium-bzw. myoglo-binkonzentration. Untersuchungen bei Männern in Halothannarkose. Anaesthesist 38: 408Google Scholar
  188. 188.
    Proakis AG, Harris GB (1978) Comparative penetration of glycopyrrolate and atropine across the blood-brain and placental barriers in anesthetized dogs. Anesthesiology 48: 339PubMedCrossRefGoogle Scholar
  189. 189.
    Pusey JM, Charlton SM, Skinner JB, Assem ESK (1987) Anaphylactoid reaction to alcuronium. Anaesthesia 42: 164PubMedCrossRefGoogle Scholar
  190. 190.
    Quill TJ, Glass PSA (1988) Vecuronium by continuous infusion: comparative study. 9th WCA Abstracts vol II: A 0538Google Scholar
  191. 191.
    Ramsey FM, Morell RC, Gerr P (1986) The priming principle: pretreatment with metocurine prior to vecuronium neuromuscular blockade. Anesthesiology 65: A 298CrossRefGoogle Scholar
  192. 192.
    Rowlands DE (1987) Harmless cutaneous reactions associated with the use of atracurium. A report of 1200 anaesthetics. Br J Anaesth 59: 693Google Scholar
  193. 193.
    Rorvik K, Husby P, Gramstad L, Vamnes JS, Bitsch-Larsen L, Koller ME (1988) Comparison of large dose vecuronium with pancuronium for prolonged neuromuscular blockade. Br J Anaesth 61: 180PubMedCrossRefGoogle Scholar
  194. 194.
    Rupp SM, Mc Christian JW, Miller RD, Taboada JA, Cronnelly R (1986) Neostigmine and endrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium or vecuronium. Anesthesiology 64: 711PubMedCrossRefGoogle Scholar
  195. 195.
    Rupp SM, Miller RD, Gencarelli P (1984) Vecuronium-induced neuromuscular blockade during enflurane, iso-flurane and halothane anesthesia in humans. Anesthesiology 60: 102PubMedCrossRefGoogle Scholar
  196. 196.
    Salmenpera M, Peltola K, Takkumen O, Heinonen J (1983) Cardiovascular effects of pancuronium and vecuronium during high-dose fentanyl anesthesia. Anesth Analg 62: 1059PubMedGoogle Scholar
  197. 197.
    Salvador A, Del Pozo E, Carlos R, Baeyens JM (1988) Differential effects of calcium channel blocking agents on pancuronium — and suxamethonium-induced neuromuscular blockade. Br J Anaesth 60: 495PubMedCrossRefGoogle Scholar
  198. 198.
    Sarner JB, Brandom BW, Woelfel SK, Dong M-L, Horn MC, Cook DR, McNulty BF, Foster VJ (1989) Clinical pharmacology of mivacurium chloride (BW 1090 U) in children during nitrous oxide — halothane and nitrous oxide — narcotic anesthesia. Anesth Analg 68: 116PubMedCrossRefGoogle Scholar
  199. 199.
    Savarese JJ, Ali HH, Antonio RP (1977) The clinical pharmacology of metocurine: dimethyltubocurarine revisited. Anesthesiology 47: 277PubMedCrossRefGoogle Scholar
  200. 200.
    Savarese JJ, Ali HH, Basta SJ, Embree PM, Scott RPF, Sunder M, Neal Weakly J, Wastila WB, El-Sayad HA (1988) The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). Anesthesiology 68: 723PubMedCrossRefGoogle Scholar
  201. 201.
    Schuh FT (1977) Zur Cholinesterase-Hemmung durch Pancuronium. Anaesthesist 26: 125PubMedGoogle Scholar
  202. 202.
    Schuh FT (1981) Pathophysiologische Bedingungen als Kontraindikationen für den Einsatz depolarisierender Muskelrelaxantien. In: Buzello W (Hrsg) Muskelrelaxan-tien. Thieme, Stuttgart New York (Intensivmed Notfall-med Anästh, Bd 30, S 112)Google Scholar
  203. 203.
    Schwarz S, Ilias W, Lackner F, Mayrhofer O, Foldes FF (1985) Rapid tracheal intubation with vecuronium: the priming principle. Anesthesiology 62: 388PubMedCrossRefGoogle Scholar
  204. 204.
    Scott RPF, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG (1985) Atracu-rium: clinical strategies for preventing histamine release and attenuating the haemodynamic response. Br J Anaesth 57: 550PubMedCrossRefGoogle Scholar
  205. 205.
    Sessler DI, Olofsson CI, Chow F (1988) Lower esophageal contractility predicts movement during skin incision: vecuronium does not decrease the MAC of halothane. Anesth Analg 67:S201CrossRefGoogle Scholar
  206. 206.
    Shanks CA (1986) Pharmakokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens. Anesthesiology 64: 72PubMedCrossRefGoogle Scholar
  207. 207.
    Shanks CA, Somogyi AA, Triggs EJ (1979) Dose-response and plasma concentration-response relationships of pancuronium in man. Anesthesiology 51: 111PubMedCrossRefGoogle Scholar
  208. 208.
    Smith CE, Donati F, Bevan DR (1988) Potency of succi-nylcholine at the diaphragm and the adductor pollicis muscle. Anesth Analg 67: 625PubMedGoogle Scholar
  209. 209.
    Smith G, Dalling R, Williams TIR (1978) Gastro-oeso-phageal pressure gradient changes produced by induction of anaesthesia and suxamethonium. Br J Anaesth 50: 1137PubMedCrossRefGoogle Scholar
  210. 210.
    Smith RB, Grenvik A (1970) Cardiac arrest following succinylcholin in patients with central nervous system injuries. Anesthesiology 33: 558PubMedCrossRefGoogle Scholar
  211. 211.
    Sold M, Lazarus G, Baar H (1987) Untersuchungen zur Antagonisierbarkeit einer Intubationsdosis Vecuronium. Anaesthesist 36: 345PubMedGoogle Scholar
  212. 212.
    Spek Van Der AFL, Fang W, Ashton-Miller JA, Stonier CS, Carlson DS, Schork MA (1988) Increased masticatory muscle stiffness during limb muscle flaccidity associated with succinylcholine administration. Anesthesiology 69: 11PubMedCrossRefGoogle Scholar
  213. 213.
    Spence AG, Barnetson RStC (1985) Reaction to vecuronium bromide. Lancet 1: 979PubMedCrossRefGoogle Scholar
  214. 214.
    Standaert FG (1985) The doughnut and its hole. Clin Anaesth 3: 243Google Scholar
  215. 215.
    Starr NJ, Sethna DH, Estafanous FG (1986) Bradycardia and asystole following the rapid administration of sufentanil with vecuronium. Anesthesiology 64: 521PubMedCrossRefGoogle Scholar
  216. 216.
    Stenlake JB, Waigh RD, Urwin J, Dewar GH, Co-ker GG (1983) Atracurium. Conception and inception. Br J Anaesth 55:3 SGoogle Scholar
  217. 217.
    Stirt JA, Grosslight KR, Bedford RF, Vollmer D (1987) „Defasciculation“ with metocurine prevents succinyleho-line-induced increases in intracranial pressure. Anesthesiology 67: 50PubMedCrossRefGoogle Scholar
  218. 218.
    Stoelting PK (1972) The hemodynamic effects of pancuronium and d-tubocurarine in anesthetized patients. Anesthesiology 36: 612PubMedCrossRefGoogle Scholar
  219. 219.
    Stoelting RK (1977) Comparison of gallamine and atropine as pretreatment before anesthetic induction and succinylcholine administration. Anesth Analg 56: 493PubMedGoogle Scholar
  220. 220.
    Stoops CM, Curtis CA, Kovach DA, Mc Cammon RL, Stoelting RK, Warren TM, Miller D, Bopp SK, Jugovic DJ, Abou-Dovia MM (1989) Hemodynamic effects of mivacurium chloride administered to patients during oxygen-sufentanil anesthesia for coronary artery bypass grafting or valve replacement. Anesth Analg 68: 333PubMedCrossRefGoogle Scholar
  221. 221.
    Stovner J, Oftedal N, Holmboe I (1975) The inhibition of cholinesterases by pancuronium. Br J Anaesth 47: 949PubMedCrossRefGoogle Scholar
  222. 222.
    Sugimori T (1986) Shortened action of succinylcholine in individuals with cholin-esterase C5 isoenzyme. Can Anaesth Soc J 33: 321PubMedCrossRefGoogle Scholar
  223. 223.
    Swerdlow BN, Holley FO (1987) Intravenous anaesthetic agents. Pharmakokinetic — pharmacodynamic relationships. Clin Pharmacokin 12: 79CrossRefGoogle Scholar
  224. 224.
    Tabaoda JA, Rupp SM, Miller RD (1986) Refining the priming principle for vecuronium during rapid — sequence induction of anesthesia. Anesthesiology 64: 243CrossRefGoogle Scholar
  225. 225.
    Taylor P (1985) Neuromuscular blocking agents. In: Gilman A, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics, 7th edn. Macmillan, New York, p 223Google Scholar
  226. 226.
    Taylor P (1985) Are neuromuscular blocking agents more efficacious in pairs? Anesthesiology 63: 1PubMedCrossRefGoogle Scholar
  227. 227.
    Thomas J, Climie CR, Mather LE (1969) The placental transfer of alcuronium. Br J Anaesth 41: 297PubMedCrossRefGoogle Scholar
  228. 228.
    Thys DM, Konstadt SN, Reich D, Hillel Z, Keusch D, Gettes M, Guffin A, Kaplan JA, Mikula S, Marvin R (1988) The effects of a new muscle relaxant, doxacurium, on left and right ventricular performance. Anesth Analg 67: S 232CrossRefGoogle Scholar
  229. 229.
    Tolmie JD, Joyce TH, Mitchell GD (1967) Succinylcholine danger in the burned patients. Anesthesiology 28: 467PubMedCrossRefGoogle Scholar
  230. 230.
    Trudell JR (1977) A unitary theory of anesthesia based on lateral phase separations in nerve membranes. Anesthesiology 46: 5PubMedCrossRefGoogle Scholar
  231. 231.
    Tryba M (1985) Wirkungsverstärkung nicht-depolarisie-render Muskelrelaxantien durch Acylaminopenicilline. Anaesthesist 34: 651PubMedGoogle Scholar
  232. 232.
    Tsui D, Graham GG, Torda DA (1987) The pharmacokinetics of atracurium isomers in vitro and in humans. Anesthesiology 67: 722PubMedCrossRefGoogle Scholar
  233. 233.
    Tullock WC, Diana P, Cook DR, Wilks DH, Bran-dom BW, Beach CA (1988) High dose vecuronium: onset and duration. Anesth Analg 67: S 235CrossRefGoogle Scholar
  234. 234.
    Ulsamer B (1988) Vecuroniumbromid: Beeinflussung der Pharmakodynamik durch Etomidat, Cimetidin und Ranitidin. Anaesthesist 37: 504PubMedGoogle Scholar
  235. 235.
    Viby-Mogensen J (1985) Interaction of other drugs with muscle relaxants. In: Katz RL (ed) Muscle relaxants. Grune & Stratton, Orlando, p 233Google Scholar
  236. 236.
    Viby-Mogensen J, Chraemmer-Jorgenson B, Ording H (1979) Residual curarization in the recovery room. Anesthesiology 50: 539PubMedCrossRefGoogle Scholar
  237. 237.
    Wainwright AP, Brodrick PM (1987) Suxamethonium in myasthenia gravis. Anaesthesia 42: 950PubMedCrossRefGoogle Scholar
  238. 238.
    Wald-Oboussier G, Lohmann Ch, Vieil B, Doehn M (1987) „Self-taming“: eine Alternative zur Prophylaxe des durch Succinylcholin induzierten Schmerzes. Anaesthesist 36: 426PubMedGoogle Scholar
  239. 239.
    Ward S, Boheimer N, Weatherley BC, Simmons RJ, Dopson TA (1987) Pharmacokinetics of atracurium and its metabolites in patient with normal renal function, and in patients in renal failure. Br J Anaesth 59: 697PubMedCrossRefGoogle Scholar
  240. 240.
    Ward S, Judge S, Corail I (1982) Pharmacokinetics of pancuronium bromide in liver failure. Br J Anaesth 54:227PGoogle Scholar
  241. 241.
    Ward S, Neill EAM (1983) Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure). Br J Anaesth 55: 1169PubMedCrossRefGoogle Scholar
  242. 242.
    Waser PG (1986) Molekulare Pharmakologie und Kinetik der Muskelrelaxanzien am Endorgan. Anästh Inten-sivmed 188: 180Google Scholar
  243. 243.
    Waser PG, Relier J (1972) Distribution and pharmacokinetics of 14C-toxiferine in rats. Agents Actions 2: 170PubMedCrossRefGoogle Scholar
  244. 244.
    Waser PG, Wiederkehr H, Chang Sin-Ren A, Kaiser-Sehünenberger E (1987) Distribution and kinetics of 14C-Vecuronium in rats and mice. Br J Anaesth 59: 1044PubMedCrossRefGoogle Scholar
  245. 245.
    Waters DJ, Mapleson WW (1971) Suxamethonium pains: hypothesis and observation. Anaesthesia 26: 127PubMedCrossRefGoogle Scholar
  246. 246.
    Watkins J (1986) Histamine release and atracurium. Br J Anaesth 58:19 SGoogle Scholar
  247. 247.
    Waud BE, Farrell L, Waud DR (1982) Lithium and neuromuscular transmission. Anesth Analg 61: 399PubMedCrossRefGoogle Scholar
  248. 248.
    Waud BE, Waud DR (1975) The effects of diethyl ether, enflurane, and isoflurane at the neuromuscular junction. Anesthesiology 42: 275PubMedCrossRefGoogle Scholar
  249. 249.
    Waud BE, Waud DR (1985) Interaction among agents that block end-plate depolarization competitively. Anesthesiology 63: 4PubMedCrossRefGoogle Scholar
  250. 250.
    Weber S, Powers DM, Byers RS, Mazloomdoost M (1988) Does age affect use of the priming principle for rapid intubation? Anesth Analg 67: S 250CrossRefGoogle Scholar
  251. 251.
    Weinstein JA, Matteo RS, Ornstein E, Schwartz AE, Goldstoff M, Thal G (1988) Pharmacodynamics of vecuronium and atracurium in the obese surgical patients. Anesth Analg 67: 1149PubMedCrossRefGoogle Scholar
  252. 252.
    Weintraub HD, Heisterkamp DV, Cooperman LH (1969) Changes in plasma potassium concentration after depolarizing blockers in anaesthetized man. Br J Anaesth 41: 1048PubMedCrossRefGoogle Scholar
  253. 253.
    Wessler I (1987) Modulation der Acetylcholin-Freiset-zung aus dem motorischen Nerven durch präsynaptische Rezeptoren. Anaesthesist [Suppl] 36: 259Google Scholar
  254. 254.
    Westra P, Vermeer GA, de Lange AR, Scaf AHJ, Meijer DKF, Wesseling H (1981) Hepatic and renal disposition of pancuronium and gallamine in patients with extrahepatic cholestasis. Br J Anaesth 53: 331PubMedCrossRefGoogle Scholar
  255. 255.
    Whittaker M (1980) Plasma Cholinesterase variants and the anaesthetist. Anaesthesia 35: 174PubMedCrossRefGoogle Scholar
  256. 256.
    Whittaker M (1986) Cholinesterase. In: Beckmann L (ed) Monographs in human genetics, vol 11. Karger, asel, p 1Google Scholar
  257. 257.
    Wierda JMKH, Karliczek GF, van der Brom RHG, Kersten-Kleef UW, Agoston S (1987) Pharmacokinetics and cardiovascular effects of pipecuronium bromide (Arduan) in CABG patients. Anesthesiology 67: A613CrossRefGoogle Scholar
  258. 258.
    Wierda JMKH, Richardson FJ, Agoston S (1989) Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl. Anesth Analg 68: 208PubMedCrossRefGoogle Scholar
  259. 259.
    Wildsmith JAW (1972) Serum pseudoCholinesterase, pregnancy and suxamethonium. Anaesthesia 27: 90PubMedCrossRefGoogle Scholar
  260. 260.
    Yate PM, Flynn PJ, Arnold RW, Weatherley BC, Simmonds RJ, Dopson T (1987) Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Br J Anaesth 59: 211PubMedCrossRefGoogle Scholar
  261. 261.
    Young WL, Matteo RS, Ornstein E (1988) Duration of action of neostigmine and pyridostigmine in the elderly. Anesth Analg 67: 775PubMedGoogle Scholar
  262. 262.
    Zsigmond EK, Down JR (1971) Plasma Cholinesterase activity in newborns and infants. Can Anaesth Soc J 18: 278PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • B. Ulsamer
  • A. Doenicke

There are no affiliations available

Personalised recommendations